Company Registration No. 03539658 (England and Wales)
ELSIPHYL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
Celixir House
Stratford Business & Technology Park
Innovation Way, Banbury Road
Stratford-upon-Avon
Warwickshire
United Kingdom
CV37 7GZ
ELSIPHYL LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
5 - 8
ELSIPHYL LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr T R Wightman
Mrs J S Wightman
Secretary
Mrs J S Wightman
Company number
03539658
Registered office
Arden House
7 Rowley Crescent
Stratford Upon Avon
Warwickshire
CV37 6UT
Accountants
TC Group
Celixir House
Stratford Business & Technology Park
Innovation Way, Banbury Road
Stratford-upon-Avon
Warwickshire
United Kingdom
CV37 7GZ
ELSIPHYL LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,172
2,641
Investment property
4
2,415,000
2,110,237
2,417,172
2,112,878
Current assets
Debtors
5
10,191
6,528
Cash at bank and in hand
241,347
123,875
251,538
130,403
Creditors: amounts falling due within one year
6
(565,429)
(516,283)
Net current liabilities
(313,891)
(385,880)
Total assets less current liabilities
2,103,281
1,726,998
Provisions for liabilities
(34,821)
Net assets
2,068,460
1,726,998
Capital and reserves
Called up share capital
1,120
1,120
Revaluation reserve
7
442,185
137,422
Profit and loss reserves
1,625,155
1,588,456
Total equity
2,068,460
1,726,998
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
ELSIPHYL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 3 -
The financial statements were approved by the board of directors and authorised for issue on 5 September 2025 and are signed on its behalf by:
Mr T R Wightman
Director
Company registration number 03539658 (England and Wales)
ELSIPHYL LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2023
1,120
137,422
1,483,784
1,622,326
Year ended 31 March 2024:
Profit and total comprehensive income
-
-
107,672
107,672
Dividends
-
-
(3,000)
(3,000)
Balance at 31 March 2024
1,120
137,422
1,588,456
1,726,998
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
38,199
38,199
Dividends
-
-
(1,500)
(1,500)
Other movements
-
304,763
-
304,763
Balance at 31 March 2025
1,120
442,185
1,625,155
2,068,460
ELSIPHYL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
1
Accounting policies
Company information
Elsiphyl Limited is a private company limited by shares incorporated in England and Wales. The registered office is Arden House, 7 Rowley Crescent, Stratford Upon Avon, Warwickshire, CV37 6UT.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
1.2
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.
1.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
25% reducing balance
Fixtures and fittings
15% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.4
Investment property
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.
1.5
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
ELSIPHYL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
0
0
ELSIPHYL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
3
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Total
£
£
£
Cost
At 1 April 2024 and 31 March 2025
6,626
5,735
12,361
Depreciation and impairment
At 1 April 2024
5,903
3,817
9,720
Depreciation charged in the year
181
288
469
At 31 March 2025
6,084
4,105
10,189
Carrying amount
At 31 March 2025
542
1,630
2,172
At 31 March 2024
723
1,918
2,641
4
Investment property
2025
£
Fair value
At 1 April 2024
2,110,237
Revaluations
304,763
At 31 March 2025
2,415,000
Fair value at 31 March 2025 is represented by:
£
Valuations 442,185
Cost 1,972,815
Total 2,415,000
If Land and Buildings had not been revalued they would have been included at the following historical cost:
2025 2024
£ £
Cost 1,972,815 1,972,815
Investment property was valued on an open market basis on 31 March 2025 by the directors.
ELSIPHYL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
10,000
6,365
Other debtors
191
163
10,191
6,528
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,114
Taxation and social security
28,893
42,488
Other creditors
536,536
472,681
565,429
516,283
7
Revaluation reserve
2025
2024
£
£
At the beginning of the year
137,422
137,422
Other movements
304,763
-
At the end of the year
442,185
137,422